Australia markets close in 50 minutes

Abbott Laboratories (ABT)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
109.48+3.55 (+3.35%)
At close: 4:02PM EDT
Show:
Income statement
Balance sheet
Cash flow
Annual
Premium required to access quarterly data
Quarterly

Income statement

All numbers in thousands
Breakdown
ttm
31/12/2019
31/12/2018
31/12/2017
31/12/2016
Total revenue
31,444,000
31,904,000
30,578,000
27,390,000
20,853,000
Cost of revenue
13,336,000
13,231,000
12,706,000
12,337,000
9,024,000
Gross profit
18,108,000
18,673,000
17,872,000
15,053,000
11,829,000
Operating expenses
Research development
2,333,000
2,440,000
2,300,000
2,235,000
1,422,000
Selling general and administrative
9,677,000
9,765,000
9,744,000
9,117,000
6,672,000
Total operating expenses
14,091,000
14,141,000
14,222,000
13,327,000
8,644,000
Operating income or loss
4,017,000
4,532,000
3,650,000
1,726,000
3,185,000
Interest expense
604,000
670,000
826,000
904,000
431,000
Total other income/expenses net
13,000
121,000
-56,000
1,285,000
-1,440,000
Income before tax
3,502,000
4,077,000
2,873,000
2,231,000
1,413,000
Income tax expense
412,000
390,000
539,000
1,878,000
350,000
Income from continuing operations
3,090,000
3,687,000
2,334,000
353,000
1,063,000
Net income
3,110,000
3,687,000
2,368,000
477,000
1,400,000
Net income available to common shareholders
3,110,000
3,687,000
2,368,000
477,000
1,400,000
Basic EPS
-
2.09
1.35
0.27
0.95
Diluted EPS
-
2.06
1.33
0.27
0.94
Basic average shares
-
1,762,503
1,755,619
1,743,602
1,472,869
Diluted average shares
-
1,781,000
1,770,000
1,749,000
1,483,000
EBITDA
-
7,761,000
6,977,000
6,156,000
3,197,000